IGHE and asthma: Although Casale and colleagues found in the PROSPERO study that baseline BEC was associated with anti-IgE–induced improvement in asthma control and lung function, the magnitude of this improvement was not considered to be clinically relevant by the investigators and was not explored along a biomarker concentration gradient (45).